Journal articleCancer2015
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.
- Journal
- Cancer
- Published
- 23 December 2014
- Citations
- 392
- Type
- Article
- License
- cc by-nc-nd
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 4
- BackgroundStereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic Cancer NCT07173387↗
- BackgroundSplit-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer NCT04289792↗
- BackgroundLosartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer NCT04106856↗
- BackgroundI125 Seed Implantation vs Stereotactic Radiotherapy for Pancreatic Cancer NCT03964064↗